Cystatin C as a potential biomarker for dosing of renally excreted drugs.
about
Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenDevelopment of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.Adherence with perindopril therapy: a pilot study using therapeutic drug monitoring of perindoprilat and an evaluation of the clearance estimation.
P2860
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@ast
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@en
type
label
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@ast
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@en
prefLabel
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@ast
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@en
P2860
P356
P1476
Cystatin C as a potential biomarker for dosing of renally excreted drugs.
@en
P2093
Nguessan Aimé Brou
P2860
P356
10.1111/BCP.12602
P407
P577
2015-05-28T00:00:00Z